CVSCVS HEALTH Corp

NYSE cvshealth.com


$ 57.24 $ -0.22 (-0.38 %)    

Wednesday, 28-Aug-2024 15:59:58 EDT
QQQ $ 468.16 $ -5.41 (-1.13 %)
DIA $ 411.36 $ -1.55 (-0.38 %)
SPY $ 558.32 $ -3.26 (-0.58 %)
TLT $ 97.88 $ -0.12 (-0.12 %)
GLD $ 231.76 $ -1.64 (-0.7 %)
$ 57.24
$ 57.19 x 100
$ 57.24 x 100
-- - --
$ 52.18 - $ 80.80
7,963,588
na
72.01B
$ 0.77
$ 10.01
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-01-2024 03-31-2024 10-Q
3 02-07-2024 12-31-2023 10-K
4 11-01-2023 09-30-2023 10-Q
5 08-02-2023 06-30-2023 10-Q
6 05-03-2023 03-31-2023 10-Q
7 02-08-2023 12-31-2022 10-K
8 11-02-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-09-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-04-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 02-16-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 02-18-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-02-2018 03-31-2018 10-Q
27 02-14-2018 12-31-2017 10-K
28 11-06-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-02-2017 03-31-2017 10-Q
31 02-09-2017 12-31-2016 10-K
32 11-08-2016 09-30-2016 10-Q
33 08-02-2016 06-30-2016 10-Q
34 05-03-2016 03-31-2016 10-Q
35 02-09-2016 12-31-2015 10-K
36 10-30-2015 09-30-2015 10-Q
37 08-04-2015 06-30-2015 10-Q
38 05-01-2015 03-31-2015 10-Q
39 02-10-2015 12-31-2014 10-K
40 11-04-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 auto-stocks-abortion-health-care-in-spotlight-at-dnc-joe-biden-uaw-president-women-affected-by-roe-v-wade-decision-headline-night-1

The first night of the Democratic National Convention (DNC) could have investors eyeing sectors like healthcare and automotive ...

 cantor-fitzgerald-reiterates-neutral-on-cvs-health-maintains-62-price-target

Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $62 price target.

 pharmacy-chains-like-cvs-health-walgreens-boots-alliance-confront-shifting-consumer-habits-and-profit-pressures

Walgreens and CVS face declining profits as falling reimbursement rates, rising costs, and competition challenge the retail pha...

 wells-fargo-maintains-equal-weight-on-cvs-health-raises-price-target-to-61

Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Equal-Weight and raises the price target from $60 ...

 deutsche-bank-maintains-hold-on-cvs-health-lowers-price-target-to-63

Deutsche Bank analyst George Hill maintains CVS Health (NYSE:CVS) with a Hold and lowers the price target from $64 to $63.

 whats-going-on-with-cvs-health-stock

CVS Health shares are trading flat during Friday's session. The company this week reported disappointing Q2 sales and lower...

 barclays-maintains-equal-weight-on-cvs-health-lowers-price-target-to-63

Barclays analyst Andrew Mok maintains CVS Health (NYSE:CVS) with a Equal-Weight and lowers the price target from $65 to $63.

 cantor-fitzgerald-maintains-neutral-on-cvs-health-raises-price-target-to-62

Cantor Fitzgerald analyst Sarah James maintains CVS Health (NYSE:CVS) with a Neutral and raises the price target from $58 to...

 evercore-isi-group-maintains-outperform-on-cvs-health-lowers-price-target-to-62

Evercore ISI Group analyst Elizabeth Anderson maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target ...

 wall-street-poised-for-second-day-of-gains-while-bank-of-japan-makes-reassurances-dollar-strengthens-against-yen-crude-prices-surge-whats-driving-markets-wednesday

The U.S.

 cvs-health-reports-mixed-q2-earnings-lowers-2024-outlook-reshuffles-segment-management

CVS Health stock dipped premarket Wednesday after mixed Q2 earnings and lowered annual profit guidance. Sales missed expectatio...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION